1.Correlation between Lipids Measured in the Interstitial Fluid from Suction Blister and the Serum
Il Joo KWON ; Sung Jay CHOE ; Seung Won JEONG ; Myungsoo JUN ; Eung Ho CHOI
Korean Journal of Dermatology 2022;60(3):159-166
Background:
Several biomarkers are measured in the interstitial fluid (IF) obtained from suction blisters that are used by dermatologists. As abnormal lipid levels can cause health problems, several studies have investigated the composition and distribution of lipids and lipoproteins in IF. However, to date, no study has focused on examining lipid profiles in the postprandial state.
Objective:
This study aimed to compare postprandial changes in serum lipid profiles and IF obtained from suction blisters and investigated their correlation.
Methods:
Fasting and postprandial levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides were measured in paired serum samples. IF was obtained from suction blisters from 20 healthy men using enzymatic-colorimetric methods.
Results:
The IF/serum ratios of TC, HDL-C, and LDL-C remained unchanged postoperatively. Postprandial levels of HDL-C and LDL-C decreased in the serum but not in IF. In both fasting and postprandial states, TC, HDL-C, and LDL-C levels in the serum were positively correlated with those in the IF.
Conclusion
The results of this study showed that lipoprotein cholesterol levels measured from suction blister fluids could be used as a biomarker to predict their serum levels regardless of food intake. Therefore, suction blister fluid sampling can be considered as a method to monitor serum lipid concentrations.
2.Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
Yong Suk JO ; Junsu CHOE ; Sun Hye SHIN ; Hyeon Kyoung KOO ; Won Yeon LEE ; Yu Il KIM ; Seung Won RA ; Kwang Ha YOO ; Ki Suck JUNG ; Hye Yun PARK ; Yong Bum PARK
Tuberculosis and Respiratory Diseases 2020;83(1):42-50
3.Differences in Endoscopic Findings of Primary and Secondary Gastric Lymphoma
Kyoungwon JUNG ; Hae Soo JEON ; Moo In PARK ; Il Hyeong CHOE ; Hyun Seung JE ; Jae Hyun KIM ; Sung Eun KIM ; Won MOON ; Seun Ja PARK
Kosin Medical Journal 2020;35(2):114-124
Objectives:
Since endoscopic findings of primary gastric lymphoma are ambiguous and diverse, it is not easy to distinguish them from gastric adenocarcinoma or secondary gastric lymphoma. The aim of this study was to investigate the difference in clinical and endoscopic features between primary gastric lymphoma and gastric involvement of lymphoma.
Methods:
Forty-eight patients were enrolled in this retrospective study between June 2008 and February 2017. The patients were divided into primary gastric lymphoma group (primary group, n = 18) and gastric involvement group (secondary group, n = 30) based on whether or not they carried gastric lesions alone. Patients’ clinical characteristics, endoscopic findings and pathologic data were retrospectively reviewed based on electronic medical records.
Results:
The mean age of patients was 63.3 ± 13.1 years and 29 patients were female (60.4%). Diffuse large B-cell lymphoma pathology (81.3%), gastric body involvement (47.9%) and ulceroinfiltrative morphology on endoscopy (43.8%) were common features. Regardless of the two groups, the initial endoscopic diagnosis was considered as lymphoma only in 41.7%. Compared with the primary group, fundus (P = 0.035) and regional lymph node (P < 0.001) were significantly associated with the secondary group. However, there was no significant difference in endoscopic findings including location, size, number, and morphology of lesion.
Conclusions
Endoscopic diagnosis of gastric lymphoma is a challenge. There is no difference in endoscopic findings between the primary and secondary groups even when confirmed separately. However, when the lesion is present in the fundus, we keep in mind the possibility of secondary gastric lymphoma.
4.Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
Yong Suk JO ; Junsu CHOE ; Sun Hye SHIN ; Hyeon Kyoung KOO ; Won Yeon LEE ; Yu Il KIM ; Seung Won RA ; Kwang Ha YOO ; Ki Suck JUNG ; Hye Yun PARK ; Yong Bum PARK
Tuberculosis and Respiratory Diseases 2020;83(1):42-50
BACKGROUND:
Fractional exhaled nitric oxide (FeNO) is regarded as a potential biomarker for identifying eosinophilic inflammation. We aimed to evaluate the clinical implication of FeNO and its influence on inhaled corticosteroids (ICS) prescription rate in Korean chronic obstructive pulmonary disease (COPD) patients.
METHODS:
FeNO level and its association with clinical features were analyzed. Changes in the prescription rate of ICS before and after FeNO measurement were identified.
RESULTS:
A total of 160 COPD patients were divided into increased (≥25 parts per billion [ppb], n=74) and normal (<25 ppb, n=86) FeNO groups according to the recommendations from the American Thoracic Society. Compared with the normal FeNO group, the adjusted odds ratio for having history of asthma without wheezing and with wheezing in the increased FeNO group were 2.96 (95% confidence interval [CI], 1.40–6.29) and 4.24 (95% CI, 1.37–13.08), respectively. Only 21 out of 74 patients (28.4%) with increased FeNO prescribed ICS-containing inhaler and 18 of 86 patients (20.9%) with normal FeNO were given ICS-containing inhaler. Previous exacerbation, asthma, and wheezing were the major factors to maintain ICS at normal FeNO level and not to initiate ICS at increased FeNO level.
CONCLUSION
Increased FeNO was associated with the history of asthma irrespective of wheezing. However, FeNO seemed to play a subsidiary role in the use of ICS-containing inhalers in real-world clinics, which was determined with prior exacerbation and clinical features suggesting Th2 inflammation.
5.Differences in Endoscopic Findings of Primary and Secondary Gastric Lymphoma
Kyoungwon JUNG ; Hae Soo JEON ; Moo In PARK ; Il Hyeong CHOE ; Hyun Seung JE ; Jae Hyun KIM ; Sung Eun KIM ; Won MOON ; Seun Ja PARK
Kosin Medical Journal 2020;35(2):114-124
Objectives:
Since endoscopic findings of primary gastric lymphoma are ambiguous and diverse, it is not easy to distinguish them from gastric adenocarcinoma or secondary gastric lymphoma. The aim of this study was to investigate the difference in clinical and endoscopic features between primary gastric lymphoma and gastric involvement of lymphoma.
Methods:
Forty-eight patients were enrolled in this retrospective study between June 2008 and February 2017. The patients were divided into primary gastric lymphoma group (primary group, n = 18) and gastric involvement group (secondary group, n = 30) based on whether or not they carried gastric lesions alone. Patients’ clinical characteristics, endoscopic findings and pathologic data were retrospectively reviewed based on electronic medical records.
Results:
The mean age of patients was 63.3 ± 13.1 years and 29 patients were female (60.4%). Diffuse large B-cell lymphoma pathology (81.3%), gastric body involvement (47.9%) and ulceroinfiltrative morphology on endoscopy (43.8%) were common features. Regardless of the two groups, the initial endoscopic diagnosis was considered as lymphoma only in 41.7%. Compared with the primary group, fundus (P = 0.035) and regional lymph node (P < 0.001) were significantly associated with the secondary group. However, there was no significant difference in endoscopic findings including location, size, number, and morphology of lesion.
Conclusions
Endoscopic diagnosis of gastric lymphoma is a challenge. There is no difference in endoscopic findings between the primary and secondary groups even when confirmed separately. However, when the lesion is present in the fundus, we keep in mind the possibility of secondary gastric lymphoma.
6.Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
Yong Suk JO ; Junsu CHOE ; Sun Hye SHIN ; Hyeon Kyoung KOO ; Won Yeon LEE ; Yu Il KIM ; Seung Won RA ; Kwang Ha YOO ; Ki Suck JUNG ; Hye Yun PARK ; Yong Bum PARK
Tuberculosis and Respiratory Diseases 2020;83(1):42-50
BACKGROUND:
Fractional exhaled nitric oxide (FeNO) is regarded as a potential biomarker for identifying eosinophilic inflammation. We aimed to evaluate the clinical implication of FeNO and its influence on inhaled corticosteroids (ICS) prescription rate in Korean chronic obstructive pulmonary disease (COPD) patients.
METHODS:
FeNO level and its association with clinical features were analyzed. Changes in the prescription rate of ICS before and after FeNO measurement were identified.
RESULTS:
A total of 160 COPD patients were divided into increased (≥25 parts per billion [ppb], n=74) and normal (<25 ppb, n=86) FeNO groups according to the recommendations from the American Thoracic Society. Compared with the normal FeNO group, the adjusted odds ratio for having history of asthma without wheezing and with wheezing in the increased FeNO group were 2.96 (95% confidence interval [CI], 1.40–6.29) and 4.24 (95% CI, 1.37–13.08), respectively. Only 21 out of 74 patients (28.4%) with increased FeNO prescribed ICS-containing inhaler and 18 of 86 patients (20.9%) with normal FeNO were given ICS-containing inhaler. Previous exacerbation, asthma, and wheezing were the major factors to maintain ICS at normal FeNO level and not to initiate ICS at increased FeNO level.
CONCLUSION
Increased FeNO was associated with the history of asthma irrespective of wheezing. However, FeNO seemed to play a subsidiary role in the use of ICS-containing inhalers in real-world clinics, which was determined with prior exacerbation and clinical features suggesting Th2 inflammation.
7.Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score.
Sang Cheol BAE ; Jin Hye CHA ; Jung Yoon CHOE ; Sung Jae CHOI ; Soo Kyung CHO ; Won Tae CHUNG ; Chung Il JOUNG ; Young Ok JUNG ; Young Mo KANG ; Dong Wook KIM ; Jinseok KIM ; Young Joo KIM ; Choong Ki LEE ; Hye Soon LEE ; Jisoo LEE ; Sang Heon LEE ; Sang Hoon LEE ; Shin Seok LEE ; Yeon Ah LEE ; Seong Su NAH ; Seung Cheol SHIM ; Gwan Gyu SONG ; Chang Hee SUH ; Soyoung WON ; Wan Hee YOO ; Bo Young YOON
Journal of Rheumatic Diseases 2018;25(2):122-130
OBJECTIVE: Productivity loss was compared by 3-stage of disease activity and associations between higher disease activity and high productivity loss were identified. METHODS: Data were extracted from Rheumatoid Arthritis (RA) Patient-reported Outcomes Research, which enrolled 2,000 RA patients (>20-year) on disease-modifying-antirheumatic-drugs (DMARDs) (≥6-month) from December 2012 to June 2013. This included 1,457 RA patients with the disease activity score (DAS-28-ESR) in their medical charts. Productivity loss in time and indirect cost was estimated using The World Health Organization Health and Work Performance Questionnaire (HPQ). Baseline characteristics and productivity loss outcomes were compared according to DAS-28-ESR groups. RESULTS: 84.4% were females, 54.2% had low DAS-28-ESR ( < 3.2), and 38.2% and 7.6% had moderate (3.2∼5.1) and high DAS-28-ESR (>5.1). Patients with moderate to high DAS-28-ESR had higher lost productivity time (LPT) and monthly costs of LPT than those with low DAS-28-ESR (time in hours: 110.0±58.4 vs. 132.4±57.2 vs. 71.5±52.0, p < 0.0001; monthly costs of LPT in 1,000 Korean won: 1,097±607 vs. 1,302±554 vs. 741±531, p < 0.0001). Multiple regression analyses revealed significant associations with high LPT in high (adjusted odds ratio [OR]=3.87, 95% confidence interval [CI]: 2.18∼6.87) and moderate DAS-28-ESR (adjusted OR=1.88, 95% CI: 1.41∼2.52) compared to low DAS-28-ESR. In addition, positive associations with high monthly costs of LPT were observed in high (adjusted OR=3.45, 95% CI: 1.98∼5.99) and moderate DAS-28-ESR (adjusted OR=1.93, 95% CI: 1.43∼2.54) compared to low DAS-28-ESR. CONCLUSION: Timely therapeutic strategies should be taken into consideration given that the RA patients with moderate to high DAS-28-ESR showed strong associations with high productivity loss for effective management of RA.
Arthritis, Rheumatoid*
;
Efficiency*
;
Female
;
Humans
;
Odds Ratio
;
Outcome Assessment (Health Care)
;
Work Performance
;
World Health Organization
8.Time Course and Characteristics of Astrocyte Activation in the Rat Brain after Injury.
Hyun Ho LEE ; Sung Choon PARK ; Il Seung CHOE ; Young KIM ; Young Soo HA
Korean Journal of Neurotrauma 2015;11(2):44-51
OBJECTIVE: After injury to the central nervous system (CNS), glial scar tissue is formed in the process of wound healing. This can be is a clinical problem because it interferes with axonal regeneration and functional recovery. It is known that intracellular proteins, including the glial fibrillary acidic protein (GFAP), nestin, and vimentin increase in the astrocytes after an injury to the CNS. By studying the time course and co-expression pattern of these intracellular proteins, this study will attempt to prove that these proteins are involved in the processes of glial scar formation. METHODS: Twenty-five male Sprague-Dawley rats were used in this study. Bregma of the cerebral cortex, an area was incised with a sharp blade, and perfusion was performed. The expressions of the intracellular proteins were assayed, while the co-localization of the intermediate filament (GFAP, nestin, and vimentin) and A2B5 were examined. RESULTS: At 12 hours, the GFAP was expressed in the white matter underlying the lesion, and in the cerebral cortex. Nestin was expressed in the astrocytes in the perilesional area after 3 days, while A2B5 was observed in the edge of the wound at 12 hours post-injury, with its expression reaching a peak at 7 days. Vimentin was detected in the white matter at 12 hours, and in the cortex, reaching a peak at 7 days. CONCLUSION: In the processes of glial scar formation, nestin, vimentin, and A2B5 were revealed in the astrocytes, and these factors may be involved in the division, proliferation, and transportation of the astrocytes.
Animals
;
Astrocytes*
;
Axons
;
Brain*
;
Central Nervous System
;
Cerebral Cortex
;
Cicatrix
;
Glial Fibrillary Acidic Protein
;
Gliosis
;
Humans
;
Intermediate Filaments
;
Male
;
Nestin
;
Perfusion
;
Rats*
;
Rats, Sprague-Dawley
;
Regeneration
;
Transportation
;
Vimentin
;
Wound Healing
;
Wounds and Injuries
9.Implementation of Hospital Examination Reservation System Using Data Mining Technique.
Hyo Soung CHA ; Tae Sik YOON ; Ki Chung RYU ; Il Won SHIN ; Yang Hyo CHOE ; Kyoung Yong LEE ; Jae Dong LEE ; Keun Ho RYU ; Seung Hyun CHUNG
Healthcare Informatics Research 2015;21(2):95-101
OBJECTIVES: New methods for obtaining appropriate information for users have been attempted with the development of information technology and the Internet. Among such methods, the demand for systems and services that can improve patient satisfaction has increased in hospital care environments. METHODS: In this paper, we proposed the Hospital Exam Reservation System (HERS), which uses the data mining method. First, we focused on carrying clinical exam data and finding the optimal schedule for generating rules using the multi-examination pattern-mining algorithm. Then, HERS was applied by a rule master and recommending system with an exam log. Finally, HERS was designed as a user-friendly interface. RESULTS: HERS has been applied at the National Cancer Center in Korea since June 2014. As the number of scheduled exams increased, the time required to schedule more than a single condition decreased (from 398.67% to 168.67% and from 448.49% to 188.49%; p < 0.0001). As the number of tests increased, the difference between HERS and non-HERS increased (from 0.18 days to 0.81 days). CONCLUSIONS: It was possible to expand the efficiency of HERS studies using mining technology in not only exam reservations, but also the medical environment. The proposed system based on doctor prescription removes exams that were not executed in order to improve recommendation accuracy. In addition, we expect HERS to become an effective system in various medical environments.
Appointments and Schedules
;
Data Mining*
;
Diagnosis
;
Electronic Health Records
;
Hospital Information Systems
;
Internet
;
Korea
;
Mining
;
Patient Satisfaction
;
Prescriptions
;
Systems Integration
10.The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
Tae Rim SHIN ; Yeon Mok OH ; Joo Hun PARK ; Keu Sung LEE ; Sunghee OH ; Dae Ryoung KANG ; Seungsoo SHEEN ; Joon Beom SEO ; Kwang Ha YOO ; Ji Hyun LEE ; Tae Hyung KIM ; Seong Yong LIM ; Ho Il YOON ; Chin Kook RHEE ; Kang Hyeon CHOE ; Jae Seung LEE ; Sang Do LEE
Journal of Korean Medical Science 2015;30(10):1459-1465
The prognostic role of resting pulmonary hyperinflation as measured by residual volume (RV)/total lung capacity (TLC) in chronic obstructive pulmonary disease (COPD) remains poorly understood. Therefore, this study aimed to identify the factors related to resting pulmonary hyperinflation in COPD and to determine whether resting pulmonary hyperinflation is a prognostic factor in COPD. In total, 353 patients with COPD in the Korean Obstructive Lung Disease cohort recruited from 16 hospitals were enrolled. Resting pulmonary hyperinflation was defined as RV/TLC > or = 40%. Multivariate logistic regression analysis demonstrated that older age (P = 0.001), lower forced expiratory volume in 1 second (FEV1) (P < 0.001), higher St. George Respiratory Questionnaire (SGRQ) score (P = 0.019), and higher emphysema index (P = 0.010) were associated independently with resting hyperinflation. Multivariate Cox regression model that included age, gender, dyspnea scale, SGRQ, RV/TLC, and 6-min walking distance revealed that an older age (HR = 1.07, P = 0.027), a higher RV/TLC (HR = 1.04, P = 0.025), and a shorter 6-min walking distance (HR = 0.99, P < 0.001) were independent predictors of all-cause mortality. Our data showed that older age, higher emphysema index, higher SGRQ score, and lower FEV1 were associated independently with resting pulmonary hyperinflation in COPD. RV/TLC is an independent risk factor for all-cause mortality in COPD.
Aged
;
Dyspnea/diagnosis/physiopathology
;
Exercise Test
;
Exercise Tolerance
;
Female
;
Forced Expiratory Flow Rates/physiology
;
Forced Expiratory Volume
;
Humans
;
Lung/*physiopathology
;
Male
;
Middle Aged
;
Prognosis
;
Pulmonary Disease, Chronic Obstructive/*diagnosis/mortality/physiopathology
;
Pulmonary Emphysema/*diagnosis/mortality/physiopathology
;
Republic of Korea
;
Residual Volume/*physiology
;
Respiratory Function Tests
;
Surveys and Questionnaires
;
Total Lung Capacity/*physiology
;
Vital Capacity
;
Walking/physiology

Result Analysis
Print
Save
E-mail